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Background: Ghana recorded the last case of indigenous wild poliovirus in 1999 but suffered two more outbreaks
in 2003 and 2008. Following the World Health Organization (WHO) guidelines, transmission was interrupted through
high routine immunisation coverage with live-attenuated oral polio vaccine (OPV), effective acute flaccid paralysis (AFP)
surveillance and supplementary immunisation activities (SIA). This article describes the results of a five-year surveillance
of AFP in polio-free Ghana, evaluate the surveillance indicators and identify areas that need improvement.
Methods: We investigated 1345 cases of AFP from children aged less than 15 years reported to the Disease Surveillance
Department from January 2009 to December 2013. Data on demographic characteristics, vaccination history, clinical
presentation and virological investigation on stool specimens collected during investigation were analysed.
Results: Of the specimens analysed, 56% were from males and 76.3% were from children less than 5 years of age.
Twenty-four percent of the children received up to 3 doses of OPV, 57% received at least 4 doses while the status of
19% was unknown. Core AFP surveillance indicators were partly met for non-polio AFP rate while the WHO target for
stool adequacy and timeliness was exceeded over the period of study. All the cases were classified virologically, however
no wild polio was found. Sixty-day follow-up was conducted for 56.3% of cases and 8.6% cases classified as compactible
with polio.
Conclusion: Both laboratory and epidemiological surveillance for AFP were efficient and many WHO targets were met.
However, due to the risk of poliovirus importation prior to global eradication, longterm surveillance is required to
provide a high degree of confidence in prevention of poliovirus infection in Ghana. Thus, efforts should be made to
strengthen regional performance and to follow–up on all AFP cases in order to establish proper diagnoses for the
causes of the AFP leading to proper care.
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The global effort to eradicate polio has become the largest
public health initiative and is spearheaded by the World
Health Organization (WHO) [1]. The characteristics
of this infectious disease range in severity from a
non-specific illness to severe flaccid paralysis with
permanent disability [2]. It primarily infects children
under 5 years of age and causes paralysis in one of
every 200 to 1000 infections [3,4]. Infection is mostly* Correspondence: jodoom@noguchi.mimcom.org
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without prior or adequate vaccination with potent and
efficacious polio vaccines, living in areas of poor hygiene
and sanitation. Nearly 95% poliovirus infection is
asymptomatic with about 2% of people experiencing
viral replication in the central nervous system which may
lead to permanent neuronal damage and paralysis [5-7].
The WHO, in order to achieve eradication, recommended
that countries conduct surveillance for cases of AFP which
allows new cases to be identified where none had been
before and can detect importations of wild polioviruses
(WPVs). Since poliovirus is not the only agent that causes
AFP, a broad case definition of all AFP including Guillianl Ltd. This is an Open Access article distributed under the terms of the Creative
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transient paralysis associated with non-polio enteroviruses
(NPEVs) infection among less than 15 years and all cases of
suspected poliomyelitis among persons of any age is used.
In order to maximise the ability of surveillance to
rapidly detect imported cases, the established performance
indicators for AFP surveillance requires that all cases of
AFP be notified and investigated as prospective polio cases,
including the collection of 2 stool samples 24 hours apart
and within 14 days of the onset of paralysis [8,9]. Reporting
should be complete, timely, and represent the geography
and demography of the country and that follow-up
examination for residual paralysis should be conducted in
at least 80% of cases [10]. The surveillance system should
also function to timely detect potential polio cases and
alert health managers to institute appropriate interventions
to interrupt poliovirus transmission and also validate the
absence of wild poliovirus circulation in countries that are
no longer reporting cases of polio [11,12].
The Expanded Programme on Immunization (EPI)
was introduced in Ghana in 1978 [13] with childhood
vaccination schedule for polio to include four doses of
live-attenuated oral polio vaccine at birth, 6, 10 and
14 months of age. The Global Polio Eradication Initiative
(GPEI) program was formally accepted in Ghana in 1996
after African Ministers of Health adopted the 1995
World Health Assembly (WHA) resolution urging
member states to implement the GPEI. This strengthened
the country to intensify routine polio immunization,
implement supplementary immunization activities (SIAs),
and introduce active AFP surveillance for poliovirus with
full laboratory support [14,15].
The last known case of poliomyelitis caused by indigenous
WPV transmission occurred in a 13-year old boy
from Bole in the Northern region of the country on
October 16, 1999 [16]. However, eight cases each due
to importations from neighbouring countries caused
polio outbreaks in 2003 and 2008 in Ghana. Following
WHO guidelines for sensitive AFP surveillance and effective
OPV immunisation, poliovirus transmission was inter-
rupted and there has been no case(s) due to WPV.
Subsequently, the country submitted documentation
to the Africa Regional Commission on Certification
(ARCC) in 2007 for recognition of polio free status
after the break in transmission of WPV after the 2003
outbreak. Though the country is yet to be awarded a
polio-free status, the thousands of AFP cases that
continue to occur annually worldwide, with some
associated with wild poliovirus [17] puts the country
at risk of WPV re-importation. With the continuous
collection of epidemiological data by the AFP surveillance
system and regular annual meetings to update the
surveillance officers, analysis of the data collected and
evaluation of the programme is essential to identifygaps in the system to improve performance. This paper
evaluates the AFP surveillance indicators and describes
the results of a five-year surveillance for AFP cases in
polio-free Ghana showing the progress made towards
polio eradication from 2009 to 2013 as well as identifying
aspects that require improvement.
Methods
Study design
Ghana has ten administrative regions with 216 districts.
The health system is organized according to national,
regional, district, sub-district, and community levels.
The total projected population of the country for 2012,
based on the growth rate of 2.5% from the 2010 national
population census was 25,460,099 with children under
15 years representing about 42%.
A retrospective study was conducted using AFP
surveillance data routinely collected between January
2009 and December 2013 by the Disease Surveillance
Department of the Ghana Health Service and the
WHO accredited Regional Reference Polio Laboratory
(RRPL). All AFP cases reported to the Disease Surveillance
Department of the Ghana Health Service during this
period from all the ten regions were included in the study.
AFP Surveillance
Ghana established AFP surveillance in 1996 to refine
immunisation strategies to eradicate polio. When a
patient meeting the AFP case definition is seen at a
health facility, the health care practitioners conduct
comprehensive investigations to rule out PV as a
cause of the paralysis. These include taking a detailed
history, conducting a systematic examination, and
collecting two stool specimens, 24 to 48 hours apart, within
14 days of onset of symptoms. The case investigation
form with information on demographic, clinical history,
vaccination history and dates of stool specimen collection
are completed to accompany the sample to the
WHO-accredited RRPL at the Noguchi Memorial
Institute for Medical Research for virus isolation and
identification.
WHO Accredited Regional Reference Polio Laboratory
The WHO-accredited RRPL in Accra, Ghana follows
standardized protocols to; i) process stool samples to
isolate PV, ii) identify PV to confirm WPV cases, iii)
differentiate the three PV serotypes (1–3), WPVs,
Sabin-like PVs and vaccine derived polioviruses (VDPVs)
by intratypic differentiation (ITD) and iv) send the WPV
and suspected VDPV isolates to a WHO Specialized Polio
Laboratory to conduct genomic sequencing to monitor
pathways of PV transmission by comparing the nucleotide
sequence of the VP1 region of the genome from PV
isolates [18]. The three standard laboratory timeliness
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isolation results within 14 days of receipt, report >80% ITD
results within 7 days of receipt of specimen and ship ≥80%
of WPV and suspected VDPV isolates to the sequencing
lab within 3 days of ITD results. The independent program-
matic standard indicator is to report ITD results for ≥80%
of isolates within 60 days of paralysis onset of persons with
AFP cases; this indicator takes into account the entire
interval from onset of paralysis through case notification,
investigation, and specimen collection, transport, and
testing. In addition to timeliness, the accuracy and
quality of laboratory testing are monitored through an
annual accreditation program of onsite reviews and
proficiency testing [18].Figure 1 Virological flow chart of AFP cases classified in Ghana betweFinal classification of AFP cases
The country has a National Polio Expert Committee
(NPEC) that meets quarterly to conduct final classification
of all AFP cases. An AFP case where two adequate stool
specimens are submitted for analysis and no poliovirus is
isolated is classified as a non-polio case (and is said to
have been discarded). A case where the stool specimens
are deemed inadequate but has no residual paralysis
after 60 days of onset of symptoms is also classified as a
non-polio case (discarded). A case that has inadequate
stool specimens and has residual paralysis after 60 days of
onset of paralysis or the patient is lost to follow up or dies
within 60 days of symptom are classified as compatible
with polio or discarded (Figure 1).en 2009 and 2013.
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The WHO has devised a set of performance indicators
to ensure that AFP surveillance is properly maintained.
We evaluated the quality of the AFP surveillance
using the WHO guidelines for minimum performance
standards [19-22].
Data analysis
Demographic data was entered in an electronic database
file (Microsoft Excel, 2003) and Epi Info version 3.5.1
(Centres for Disease Control and Prevention, Atlanta,
United States). Frequencies and tables were generated
using Microsoft Excel. To compare percentages, Pearson
Chi- Square test were performed using SPSS 17.0. A
p value <0.05 was considered as significant.
Ethical considerations
Waiver for ethical approval for the study was obtained
from the Institutional Review Board of the Noguchi
Memorial Institute for Medical Research. Approval
was also given by the Surveillance Department of the
Ghana Health Service. We protected the confidentiality of
patients through use of codes.
Results
Stool samples from a total of 1, 345 AFP cases throughout
the country collected from 2009 to 2013 were processed
in the WHO accredited RRPL. All ten regions in the
country provided samples within the five years of study
with the majority from Ashanti Region. Of the specimens
analysed, 56% were from males and 76.3% were from chil-
dren less than 5 years of age (Table 1). The immunizationTable 1 Proportions of AFP by year, age, sex, OPV doses
and clinical symptoms in Ghana, 2009-2013
Variable Year
Age 2009 2010 2011 2012 2013
<5 80.6 79.2 75.7 81.4 75.3
5-15 19.4 20.8 23.3 18.6 23.3
>15 0 0 1 0 1.4
Sex
Male 55 53 56 59 56
Female 45 47 44 41 44
OPV doses
≤3 25.6 27 21.9 23.5 20
≥4 58.4 53 58 58.5 60.5
Unknown 16.0 20 20.1 18 19.5
Clinical condition
Sudden onset of paralysis 92.6 100 91 97 98
Fever 72.6 87.8 80 90.5 85.8
Asymmetrical 68.7 70 62 63.8 64.8status indicated that 24% of the children had received up
to 3 doses of OPV, 54% had received at least 4 doses while
the status of 19% of the children was unknown. As shown
in Table 1, 1311 (97.5%) of the AFP cases had complete
paralysis within 3 days of onset, 1133 (84.2%) had fever at
the onset of paralysis and 871 (64.8%) had asymmetric
paralysis.
Figures 2 and 3 show the evolution of the more
representative AFP performance indicators in Ghana
during the period of study and include the performance
target for each indicator established by WHO. The most
important AFP indicator, non-polio AFP rate, which is the
measure of the sensitivity of the system, reached
acceptable values in 2009, 2011 and 2013. However, the
rate of AFP cases due to causes other than poliomyelitis
was well above the WHO target of 2 per 100,000 children
under 15 years of age. Nevertheless, none of the ten
regions consistently met the target for the period. Ashanti
region reached the target in 2011 and 2013 while the
Eastern and Western regions met the target in 2009. The
Greater Accra region however, continuously failed to
achieve the target throughout the period (Figure 2).
The average national annual performance for the
proportion of AFP cases with 2 adequate stool specimens
fell below the 80% target in 2009 and 2010 but increased
from 79.2% in 2010 to 82.5% in 2011 and to 86.7% in 2013
showing much improvement in the indicator. This was
evident at the regional level where 5 of the 10 regions
consistently met the target from 2011 to 2013. Of the
10 regions, six met the target in 2011, eight in 2012
and nine in 2013 indicating an improvement in the
system. Nevertheless, the Greater Accra only met the
target in 2010 while Western region achieve the target in
2012 and 2013 (Figure 3).
Despite the occasional slight drop in these two indicators,
timeliness of arrival of samples to the WHO accredited
polio lab was exceeded by the national for the study periodFigure 2 Percentage of AFP cases with stool adequacy by year
of the 10 region of Ghana, 2009–2013. GAR-Greater Accra,
ASH-Ashanti, EAS- Eastern, WES- Western, UPE- Upper East, UPW- Upper
West, NOR- Northern, VOL- Volta, CEN- Central, BAR- Brong Ahafo and
GHA- Ghana.
Figure 3 Annualized non-polio AFP rate by year of the 10
region of Ghana, 2009–2013. GAR-Greater Accra, ASH-Ashanti,
EAS- Eastern, WES- Western, UPE- Upper East, UPW- Upper West,
NOR- Northern, VOL- Volta, CEN- Central, BAR- Brong Ahafo and
GHA- Ghana.
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considers the relative closer proximity of Greater
Accra Region to the Polio laboratory as compared with
other regions. Laboratory indicators including timeliness of
reporting of virus isolation results, intratypic differentiation
results, non-polio enterovirus isolation rate and sending of
isolates for genomic sequencing were all met. The Polio
laboratory was fully accredited over the period of study
when it passed all the proficiency testing panels and
on-site accreditation exercise except for 2009 when it
was partially accredited for failing to obtain valid results
for the cell sensitivity testing.
Final classification of all AFP cases using WHO
virological classification by the Polio Expert Committee
indicated that 36%, 27%, 16%, 28% and 25% of the districts
did not report any AFP case in 2009, 2010, 2011, 2012 and
2013 respectively. Sixty-day follow up was conducted for
770 (57.2%) and significant (p = 0.008) proportion of the
children were found with residual paralysis. Furthermore,
the classification associated 21 (1.6%) and 17 (1.3%) cases
of residual paralysis with Sabin-like poliovirus (P = 0.289)
and non-polio enterovirus (P = 0.398) respectively with no
statistical difference. No clear diagnosis was associatedTable 2 AFP surveillance performance indicators in Ghanafro
Parameter
Number of AFP cases investigated
Annualized non-polio AFP rate 2/100,000 < 15 yrs population
Proportion of AFP cases with 2 stool specimens collected within 14 days of o
Proportion of stool specimens arriving at national level within 3 days of bein
Proportion of stool specimens arriving at national lab in good condition
Proportion of stool specimens for which lab results were sent within 14 days
Proportion of stool specimens from which non-polio enterovirus was isolatedwith the remaining 95 (7.1%) residual paralysis which
could possibly be caused by Guillian-Barré Syndrome,
Transverse myelitis or meningitis. Of the 1,345 AFP cases
classified, 1105 (82.2%) cases from which adequate stools
specimens were collected with no virus isolation from the
lab and with no residual paralysis after 60-day follow up
were discarded as non-polio AFP. The Committee further
classified 116 (8.6%) of the cases as compactible with
polio, 25 (1.9%) lost to follow-up and 14 (1%) died before
follow-up was due (Table 3). None of the cases were
classified as polio.
Discussion
Our study represents a comprehensive national surveillance
of AFP in Ghana and reports the results of a five-year
evaluation of AFP surveillance indicators from 2009 to
2013 when the country did not report any wild poliovirus
case(s).
We evaluated the age distribution of AFP cases which
is also a risk factor and found those below the age of
5 years (59 months) to be 74.4%. This is consistent with a
study conducted in Ibadan [23] which reported AFP cases
in children <5 to be 74.3%, but higher than a report from
Marches region (37%) in Italy [24] and lower than studies
from Borno State [25] and India [26] which reported
82.5% and 90% respectively. The frequency of AFP was
found to be consistently higher over the period of study
among boys than girls with the mean incidence rate of
55.8% and 44.2% for boys and girls respectively but the
difference was not statistically significant (p = 0.074).
D’Errico et al. conducted a survey in Italy [24] and
reported similar findings of higher incidence of AFP
among boys than among girls. The study found higher
proportion of the children with fever at onset of paralysis
which progressed within 3 days with asymmetric paralysis,
most occurring in the right-leg. We also evaluated symptom
like fever at onset and found 97.5% of cases which was
higher than that reported by Sevencan et al. [27], who
found 15% of AFP cases with prodromal fever in Turkey.
Vaccination coverage with 4 doses of OPV among AFP
cases was 80%. This was because parents and guardiansm 2008-2013
Year
Target 2009 2010 2011 2012 2013
- 308 221 275 199 342
≥2 2.48 1.83 2.2 1.64 2.69
nset of paralysis 80% 75.4 79.2 82.5 84.4 86.7
g sent (%) 80% 86.6 87 84.7 85.9 86.0
90% 96.4 98.2 97.8 97.5 98.3
of receipt at the lab (%) 80% 100 100 100 100 100
(%) 10% 10 13.2 22.2 21.2 22
Table 3 Final classification of AFP cases by the National Polio Expert Committee
Final classification of AFP cases (%) P-value
2009 2010 2011 2012 2013
Expected AFP cases 102 204 216 222 223 0.001
Total received and classified 308 (302) 221 (108) 275 (127) 199 (89.6) 342 (153) 0.001
Discarded 275 (89.3) 175 (89.6) 227 (82.5) 168 (84.4) 297 (86.8) <0.001
Cases followed up after 60 days 156 (50.5) 199 (58.2) 181 (53) 190 (55.8) 219 (64) <0.001
Residual paralysis 60 (19.5) 43 (19.2) 38 (13.9) 25 (12.6) 55 (16.2) 0.008
Sabin 1 2 4 5 9 0.289
NPEV 3 4 1 1 8 0.398
Others 22 13 11 18 31 0.056
Compatibles 33 23 17 18 25 0.242
Lost to follow up 5 5 3 9 3 0.030
Died 2 5 3 2 2 0.072
Silent districts 61 (36) 46 (27) 27 (16) 48 (28) 43 (25) 0.001
P-value <0.05 is considered significant.
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OPV doses their children had taken or had misplaced
the road-to-health cards though they claimed the
children had received some OPV vaccination. This
also indicates that the actual vaccine coverage with ≥4
doses could be higher than 80% perhaps giving no
room for susceptible children who may help to
sustain transmission of poliovirus in the country over
the 5-year period. This is evident in Table 4 that OPV
vaccination coverage for both routine and SIA are high. It
is also significant to note that reduced immunization
coverage may also have serious consequences in countries
that use OPV, as was recently demonstrated by two
outbreaks of wild poliovirus in Ghana in 2003 and
2008 when there was a reduced NIDs activity in 2002
and 2007 in the country [16].
The results of the study further show that surveillance
indicators have improved within the five-year study period.Table 4 Summary of polio immunization activities in Ghana 2
Year NID/SNID Date conducted <5 yrs old targeted <5 y
2009 NID 12-14th Feb 4,759.19 4,781
2009 NID 27-29th Mar 4,759.19 4,988
2010 NID 5-7 Mar 5,095,044 5,258
2010 NID 23-25 April 5,095,044 5,201
2011 NID 24-26 Mar 5,285,575 5,462
2011 SNID 18-20 Aug 5,285,575 5,434
2011 NID 27-29 Oct 746.089 757,9
2012 NID 22-24 Mar 5,392,426 5,627
2013 NID 6-8 June 5,391,064 5,596
2013 NID 24-26 Oct 5,391,064 5,164
NID National immunization days.
SNID Sub-national immunization days.The over-all performance for stool adequacy rate increased
from 2009 to 2010 and exceeded the WHO target from
2011 to 2013. However, the regional distribution of this
quality indicator varied with only Eastern and Northern
regions meeting the target throughout the five-year period
while Greater Accra met it only in 2010. Additionally,
analysis of our data indicated that the eight regions that
could not meet their target throughout the five years failed
to collect 2 separate specimens within 14 days of onset of
paralysis. This is a surveillance failure and as Ghana pushes
to be declared a polio-free country, regional surveillance
officers must be encouraged to step-up their efforts to
achieve the criteria once an AFP case was notified and
investigated.
One of the criteria for polio-free certification is the
detection and investigation of all cases of non-polio AFP
in the population <15 years old. It is expected in such
polio-free regions to have incidence of AFP to be at009-2013
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cumulative national performance only met the target
in 2009, 2011 and 2013. Three regions; Brong Ahafo,
Upper West and Upper East performed very well by
meeting the target throughout the 5-year period but
the overall national performance dropped because
some regions under performed. The performance of
six regions was inconsistent while Greater Accra region
could not achieve the target in any of the years. It is
possible that these regions can become pockets of
transmission where polio virus circulation could go
undetected if the virus is imported into the country.
Efforts should therefore be made to strengthen the
regional AFP surveillance system as well as sensitization
of the medical staff towards the importance of detecting
and reporting every AFP case to increase the sensitivity of
the surveillance system.
WHO has specified timeliness of transportation of
stool specimens for AFP surveillance, at least 80% of
stool specimens to arrive at the polio laboratory within
72 hours of sending from the field [28]. Our results
indicated that the country performed well above the
target throughout the study period. This was made
possible due to an efficient and special arrangements
with the courier companies to collect specimens from
the regional offices and directly send them to the polio
lab. Another indicator used to evaluate the reliability
and viability of stool specimen shipped to the laboratory
for viral isolation is the non-polio enterovirus isolation
rate. It is expected that at least 10% of stool specimens
dispatched to the laboratory should yield NPEV. Our
report shows that the national annual average of
non-polio enterovirus isolation rate increased from
10% in 2009 to 13.2% in 2010 and had since remained
above 20% from 2011–2013. Similar high NPEV isolation
rate of 17.6% was reported in Egypt [29] 15.4% in Kerkuk
[30], and 14.6% in Nigeria [31]. The polio laboratory has
within the study period achieved full WHO accreditation
apart from 2009 when it was partially accredited. Though
the polio lab passed the proficiency test and the on-site
visit exercise in 2009, it failed to obtain a valid result for
the cell sensitivity testing and therefore was not fully
accredited. Although the cell sensitivity is very crucial in
the lab for the isolation of enteroviruses, valid test results
are necessary to authenticate the test done and results
obtained.
One of the limitations of this study was that we did
not establish the exact diagnosis of AFP cases with
negative stool specimens or the final diagnosis in a
substantial majority of cases that left the children
with residual paralysis. Final classification of all AFP cases
by the National Polio Expert committee identified some
silent districts that have population of 100,000 children
less than 15 years not reporting any AFP case in each ofthe years. In such districts, poliovirus transmission
and circulation could go undetected especially when
herd immunity has not been achieved and there is an
importation of wild poliovirus. Clinicians and surveillance
officers in these areas should be trained and motivated to
conduct active search for AFP cases. Using the virological
classification set by WHO, no case(s) were classified as
poliomyelitis but 116 cases were classified as compatible
with polio. Clustering of compatibles occurred in Central
region in 2010, Eastern region in 2011 and 2012 and in
Greater Accra region in 2013. To reduce the number of
compatibles in future, stool collection must be done
within 14 days of onset of paralysis. Even though 14
Sabin-like polioviruses and 12 NPEVs left the children
with residual paralysis, the cause for 76 residual paralyses
was not determined. This is a setback to the program
since AFP is a clinical condition with a wide range of
possible differential diagnoses; accurate diagnosis of
the cause of AFP is important for guiding therapy
and prognosis. AFP case investigation should always
aim at isolating the reason for the paralysis and the
clinicians and surveillance officers should follow up
all investigated cases and make certain that the final
diagnoses are accurately captured on the AFP surveillance
database [32].
Conclusion
The study indicated that the AFP surveillance system
was efficient over the past five years in Ghana, meeting
most of the WHO established epidemiological and
laboratory indicators. The system has its strength in
timely transportation of stool specimen, stool specimens
arriving in the lab in good condition, good laboratory
performing standards, annual surveillance review meetings
and up-to-date database. In addition to maintaining these
best practices, the two most important AFP surveillance
indicators, proportion of stool adequacy and non-polio
AFP rates have to be strengthened to better enhance the
overall performance especially in regions like Greater
Accra which failed to meet most of the targets. Due to the
risk of poliovirus importation prior to global eradication,
longterm surveillance is required to provide a high
degree of confidence in freedom from poliovirus
infection in Ghana. The proportion of AFP cases follow
up after 60 days of onset is deplorable and efforts
should be made to follow all the AFP cases in order
to establish proper diagnoses for the cause of the
AFP leading to proper care. In this regard, clinicians,
surveillance officers and health workers involved in
the AFP surveillance activities have to be strengthened
through sensitization meetings and motivation to detect,
investigate, collect, transport, report and conduct 60-days
follow up to fully meet the WHO standards for the
eradication goals.
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